Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

ConditionMelanoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorVanderbilt-Ingram Cancer Center

About this trial

The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.

Eligibility criteria

Qualifiers

Pathologically-proven diagnosis of melanoma.

Patient must have a test or procedure that has the potential to provide left-over tissue that can be banked for future research purposes OR the patient has already had a diagnostic or therapeutic procedure but who has not yet been approached to participate is also eligible.

Disqualifiers

Any patient with significant contraindications to venipuncture (e.g., severe anemia) will be excluded from blood collection procedures. However, if the patient provides consent and a paraffin-embedded block or 10-15 unstained slides of their tissue diagnosis, they will not be excluded from this protocol.

Any patient unable or unwilling to provide consent.

Trial design

Treatments tested in this trial

  • Tissue and blood collection

Treatment groups

No treatment groups listed